
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Résultat de la recherche
13 recherche sur le mot-clé 'Intellectual Disability/genetics'
Visionner les documents numériques
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche
Faire une suggestionClinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description / Damien WRIGHT in Journal of Neurodevelopmental Disorders, 14 (2022)
![]()
[article]
Titre : Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description Type de document : texte imprimé Auteurs : Damien WRIGHT, Auteur ; Aisling KENNY, Auteur ; Sarah ELEY, Auteur ; Andrew G. MCKECHANIE, Auteur ; Andrew C. STANFIELD, Auteur Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/epidemiology Caregivers Child Epilepsy/complications/genetics Humans Intellectual Disability/genetics Parents ras GTPase-Activating Proteins/genetics Behavioural phenotype Intellectual disability, Autism SYNGAP1-related ID received consultancy fees from GW Pharma. ACS has previously received grants and consultancy fees from Novartis and Roche. Index. décimale : PER Périodiques Résumé : BACKGROUND: SYNGAP1-related intellectual disability (ID) is a recently described neurodevelopmental disorder that is caused by pathogenic variation in the SYNGAP1 gene. To date, the behavioural characteristics of this disorder have mainly been highlighted via the prevalence of existing diagnoses in case series. We set out to detail the behavioural features of this disorder by undertaking interviews with those who have a child with SYNGAP1-related ID to allow them to describe their child's behaviour. METHODS: We conducted 27 semi-structured interviews with parents and caregivers which covered basic information (e.g., age, gender), family history, perinatal history, past medical history, developmental history, epilepsy, behavioural history, and a general description of their child's behaviour. RESULTS: Using a mixed quantitative and qualitative approach, the responses from the parents indicated that those with SYNGAP1-related ID showed high rates of autism spectrum disorder (52%), difficulties with fine and gross motor skills, delays in language development, and a high prevalence of epilepsy (70%). A qualitative analysis highlighted their general behaviour affected the themes of daily living skills, distress-related behaviours, emotional regulation, difficulties with change, a lack of danger awareness, and sensory differences. Sensory features described involved auditory, visual, tactile, gustatory, and proprioceptive themes. CONCLUSIONS: Our findings and behavioural descriptions provide important insights as well as implications for the diagnosis and care of those with SYNGAP1-related ID. En ligne : https://dx.doi.org/10.1186/s11689-022-09437-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=574
in Journal of Neurodevelopmental Disorders > 14 (2022)[article] Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description [texte imprimé] / Damien WRIGHT, Auteur ; Aisling KENNY, Auteur ; Sarah ELEY, Auteur ; Andrew G. MCKECHANIE, Auteur ; Andrew C. STANFIELD, Auteur.
Langues : Anglais (eng)
in Journal of Neurodevelopmental Disorders > 14 (2022)
Mots-clés : Autism Spectrum Disorder/epidemiology Caregivers Child Epilepsy/complications/genetics Humans Intellectual Disability/genetics Parents ras GTPase-Activating Proteins/genetics Behavioural phenotype Intellectual disability, Autism SYNGAP1-related ID received consultancy fees from GW Pharma. ACS has previously received grants and consultancy fees from Novartis and Roche. Index. décimale : PER Périodiques Résumé : BACKGROUND: SYNGAP1-related intellectual disability (ID) is a recently described neurodevelopmental disorder that is caused by pathogenic variation in the SYNGAP1 gene. To date, the behavioural characteristics of this disorder have mainly been highlighted via the prevalence of existing diagnoses in case series. We set out to detail the behavioural features of this disorder by undertaking interviews with those who have a child with SYNGAP1-related ID to allow them to describe their child's behaviour. METHODS: We conducted 27 semi-structured interviews with parents and caregivers which covered basic information (e.g., age, gender), family history, perinatal history, past medical history, developmental history, epilepsy, behavioural history, and a general description of their child's behaviour. RESULTS: Using a mixed quantitative and qualitative approach, the responses from the parents indicated that those with SYNGAP1-related ID showed high rates of autism spectrum disorder (52%), difficulties with fine and gross motor skills, delays in language development, and a high prevalence of epilepsy (70%). A qualitative analysis highlighted their general behaviour affected the themes of daily living skills, distress-related behaviours, emotional regulation, difficulties with change, a lack of danger awareness, and sensory differences. Sensory features described involved auditory, visual, tactile, gustatory, and proprioceptive themes. CONCLUSIONS: Our findings and behavioural descriptions provide important insights as well as implications for the diagnosis and care of those with SYNGAP1-related ID. En ligne : https://dx.doi.org/10.1186/s11689-022-09437-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=574 Deciphering the genetic basis of developmental language disorder in children without intellectual disability, autism or apraxia of speech / Marion LESIEUR-SEBELLIN ; Karine SIQUIER-PERNET ; Geoffroy DELPLANCQ ; Marlene RIO ; Mélanie PARISOT ; Patrick NITSCHKÉ ; Cristina RODRIGUEZ-FONTENLA ; Alison BODINEAU ; Lucie NARCY ; Emilie SCHLUMBERGER ; Vincent CANTAGREL ; Valérie MALAN in Molecular Autism, 16 (2025)
![]()
[article]
Titre : Deciphering the genetic basis of developmental language disorder in children without intellectual disability, autism or apraxia of speech Type de document : texte imprimé Auteurs : Marion LESIEUR-SEBELLIN, Auteur ; Karine SIQUIER-PERNET, Auteur ; Geoffroy DELPLANCQ, Auteur ; Marlene RIO, Auteur ; Mélanie PARISOT, Auteur ; Patrick NITSCHKÉ, Auteur ; Cristina RODRIGUEZ-FONTENLA, Auteur ; Alison BODINEAU, Auteur ; Lucie NARCY, Auteur ; Emilie SCHLUMBERGER, Auteur ; Vincent CANTAGREL, Auteur ; Valérie MALAN, Auteur Article en page(s) : 10 p. Langues : Anglais (eng) Mots-clés : Humans Male Female Child Language Development Disorders/genetics Apraxias/genetics Child, Preschool Intellectual Disability/genetics DNA Copy Number Variations Adolescent Genetic Predisposition to Disease 15q13.3 locus 16p11.2 locus Autism Developmental language disorder Intellectual disability Neurodevelopmental disorders ZNF292 use the data for research and publication purposes. Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: Written informed consent was obtained from all individuals. All studies were carried out in accordance with the declaration of Helsinki and were approved by a national ethics committee (CPP Ile de France, RIPH2G reference DI 24.01180.000212, N°2024-A00519-38, CPP reference 29-2024, promoter reference C23-79 promoter: Inserm). ClinicalTrials.gov Identifier: NCT06660108. Index. décimale : PER Périodiques Résumé : BACKGROUND: Developmental language disorder (DLD) refers to children who present with language difficulties that are not due to a known biomedical condition or associated with autism spectrum disorder (ASD) or intellectual disability (ID). The clinical heterogeneity of language disorders, the frequent presence of comorbidities, and the inconsistent terminology used over the years have impeded both research and clinical practice. Identifying sub-groups of children (i.e. DLD cases without childhood apraxia of speech (CAS)) with language difficulties is essential for elucidating the underlying genetic causes of this condition. DLD presents along a spectrum of severity, ranging from mild speech delays to profound disturbances in oral language structure in otherwise typically intelligent children. The prevalence of DLD is ~ 7-8% or 2% if severe forms are considered. This study aims to investigate a homogeneous cohort of DLD patients, excluding cases of ASD, ID or CAS, using multiple genomic approaches to better define the molecular basis of the disorder. METHODS: Fifteen families, including 27 children with severe DLD, were enrolled. The majority of cases (n = 24) were included in multiplex families while three cases were sporadic. This resulted in a cohort of 59 individuals for whom chromosomal microarray analysis and exome or genome sequencing were performed. RESULTS: We identified copy number variants (CNVs) predisposing to neurodevelopmental disorders with incomplete penetrance and variable expressivity in two families. These CNVs (i.e., 15q13.3 deletion and proximal 16p11.2 duplication) are interpreted as pathogenic. In one sporadic case, a de novo pathogenic variant in the ZNF292 gene, known to be associated with ID, was detected, broadening the spectrum of this syndrome. LIMITATIONS: The strict diagnostic criteria applied by our multidisciplinary team, including speech-language physicians, neuropsychologists, and paediatric neurologists, resulted in a relatively small sample size, which limit the strength of our findings. CONCLUSION: These findings highlight a common genetic architecture between DLD, ASD and ID, and underline the need for further investigation into overlapping neurodevelopmental pathways. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06660108. En ligne : https://dx.doi.org/10.1186/s13229-025-00642-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=555
in Molecular Autism > 16 (2025) . - 10 p.[article] Deciphering the genetic basis of developmental language disorder in children without intellectual disability, autism or apraxia of speech [texte imprimé] / Marion LESIEUR-SEBELLIN, Auteur ; Karine SIQUIER-PERNET, Auteur ; Geoffroy DELPLANCQ, Auteur ; Marlene RIO, Auteur ; Mélanie PARISOT, Auteur ; Patrick NITSCHKÉ, Auteur ; Cristina RODRIGUEZ-FONTENLA, Auteur ; Alison BODINEAU, Auteur ; Lucie NARCY, Auteur ; Emilie SCHLUMBERGER, Auteur ; Vincent CANTAGREL, Auteur ; Valérie MALAN, Auteur . - 10 p.
Langues : Anglais (eng)
in Molecular Autism > 16 (2025) . - 10 p.
Mots-clés : Humans Male Female Child Language Development Disorders/genetics Apraxias/genetics Child, Preschool Intellectual Disability/genetics DNA Copy Number Variations Adolescent Genetic Predisposition to Disease 15q13.3 locus 16p11.2 locus Autism Developmental language disorder Intellectual disability Neurodevelopmental disorders ZNF292 use the data for research and publication purposes. Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: Written informed consent was obtained from all individuals. All studies were carried out in accordance with the declaration of Helsinki and were approved by a national ethics committee (CPP Ile de France, RIPH2G reference DI 24.01180.000212, N°2024-A00519-38, CPP reference 29-2024, promoter reference C23-79 promoter: Inserm). ClinicalTrials.gov Identifier: NCT06660108. Index. décimale : PER Périodiques Résumé : BACKGROUND: Developmental language disorder (DLD) refers to children who present with language difficulties that are not due to a known biomedical condition or associated with autism spectrum disorder (ASD) or intellectual disability (ID). The clinical heterogeneity of language disorders, the frequent presence of comorbidities, and the inconsistent terminology used over the years have impeded both research and clinical practice. Identifying sub-groups of children (i.e. DLD cases without childhood apraxia of speech (CAS)) with language difficulties is essential for elucidating the underlying genetic causes of this condition. DLD presents along a spectrum of severity, ranging from mild speech delays to profound disturbances in oral language structure in otherwise typically intelligent children. The prevalence of DLD is ~ 7-8% or 2% if severe forms are considered. This study aims to investigate a homogeneous cohort of DLD patients, excluding cases of ASD, ID or CAS, using multiple genomic approaches to better define the molecular basis of the disorder. METHODS: Fifteen families, including 27 children with severe DLD, were enrolled. The majority of cases (n = 24) were included in multiplex families while three cases were sporadic. This resulted in a cohort of 59 individuals for whom chromosomal microarray analysis and exome or genome sequencing were performed. RESULTS: We identified copy number variants (CNVs) predisposing to neurodevelopmental disorders with incomplete penetrance and variable expressivity in two families. These CNVs (i.e., 15q13.3 deletion and proximal 16p11.2 duplication) are interpreted as pathogenic. In one sporadic case, a de novo pathogenic variant in the ZNF292 gene, known to be associated with ID, was detected, broadening the spectrum of this syndrome. LIMITATIONS: The strict diagnostic criteria applied by our multidisciplinary team, including speech-language physicians, neuropsychologists, and paediatric neurologists, resulted in a relatively small sample size, which limit the strength of our findings. CONCLUSION: These findings highlight a common genetic architecture between DLD, ASD and ID, and underline the need for further investigation into overlapping neurodevelopmental pathways. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06660108. En ligne : https://dx.doi.org/10.1186/s13229-025-00642-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=555 Novel ANKRD17 variants implicate synaptic and mitochondrial disruptions in intellectual disability and autism spectrum disorder / Dan XIA in Journal of Neurodevelopmental Disorders, 17 (2025)
![]()
[article]
Titre : Novel ANKRD17 variants implicate synaptic and mitochondrial disruptions in intellectual disability and autism spectrum disorder Type de document : texte imprimé Auteurs : Dan XIA, Auteur ; Yuanyuan XU, Auteur ; Zhanwen HE, Auteur ; Rui CHEN, Auteur ; Xiaoqin XIAO, Auteur ; Xiaojuan LI, Auteur ; Kewen DENG, Auteur ; Shuyun DENG, Auteur ; Lina ZHANG, Auteur ; Jieming ZHANG, Auteur ; Xiaofang PENG, Auteur ; Zhe MENG, Auteur ; Ruohao WU, Auteur ; Dilong WANG, Auteur ; Zulin LIU, Auteur ; Hui CHEN, Auteur ; Lu LI, Auteur ; Liyang LIANG, Auteur Langues : Anglais (eng) Mots-clés : Child Humans Male Autism Spectrum Disorder/genetics Intellectual Disability/genetics Mitochondria/genetics/metabolism Synapses ANKRD17 haploinsufficiency Autism Spectrum Disorder (ASD) Intellectual Disability (ID) Mitochondrial inhibition Synaptic protein abnormalities reviewed and approved by the Ethics Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen University (Ethical code: SYSEC-KY-KS-2023–153 and BAP20230154). Competing interests: The authors declare no competing interests. Index. décimale : PER Périodiques Résumé : ANKRD17 has recently been implicated in intellectual disability (ID) and autism spectrum disorder (ASD); however, the underlying molecular mechanisms remain unclear. Using trio whole-exome sequencing (Trio-WES) and chromosomal microarray analysis (CMA), we identified two unrelated cases with novel de novo heterozygous ANKRD17 variants. Case 1 describes a fetus with multiple congenital anomalies, where genetic analysis revealed a microdeletion at 4q13.3 truncating the ANKRD17 gene. Case 2 involves a 12-year-old male presenting with mild ID and progressive social impairments, associated with a NM_032217.5: c.1252 C > T (p.Arg418*) variation in ANKRD17. Our study highlighted in mouse models an association between Ankrd17 haploinsufficiency and deficits in social behavior, spatial learning and memory, as well as elevated anxiety. Furthermore, our studies suggest dysregulation of synaptic proteins and mitochondrial function, along with impaired neural circuits following Ankrd17 knockdown. These results expand the genetic and phenotypic spectrum of ANKRD17-related disorders, underscore the critical role of mitochondrial dysfunction in the pathophysiology of ANKRD17-related ID and ASD. En ligne : https://dx.doi.org/10.1186/s11689-025-09619-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=576
in Journal of Neurodevelopmental Disorders > 17 (2025)[article] Novel ANKRD17 variants implicate synaptic and mitochondrial disruptions in intellectual disability and autism spectrum disorder [texte imprimé] / Dan XIA, Auteur ; Yuanyuan XU, Auteur ; Zhanwen HE, Auteur ; Rui CHEN, Auteur ; Xiaoqin XIAO, Auteur ; Xiaojuan LI, Auteur ; Kewen DENG, Auteur ; Shuyun DENG, Auteur ; Lina ZHANG, Auteur ; Jieming ZHANG, Auteur ; Xiaofang PENG, Auteur ; Zhe MENG, Auteur ; Ruohao WU, Auteur ; Dilong WANG, Auteur ; Zulin LIU, Auteur ; Hui CHEN, Auteur ; Lu LI, Auteur ; Liyang LIANG, Auteur.
Langues : Anglais (eng)
in Journal of Neurodevelopmental Disorders > 17 (2025)
Mots-clés : Child Humans Male Autism Spectrum Disorder/genetics Intellectual Disability/genetics Mitochondria/genetics/metabolism Synapses ANKRD17 haploinsufficiency Autism Spectrum Disorder (ASD) Intellectual Disability (ID) Mitochondrial inhibition Synaptic protein abnormalities reviewed and approved by the Ethics Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen University (Ethical code: SYSEC-KY-KS-2023–153 and BAP20230154). Competing interests: The authors declare no competing interests. Index. décimale : PER Périodiques Résumé : ANKRD17 has recently been implicated in intellectual disability (ID) and autism spectrum disorder (ASD); however, the underlying molecular mechanisms remain unclear. Using trio whole-exome sequencing (Trio-WES) and chromosomal microarray analysis (CMA), we identified two unrelated cases with novel de novo heterozygous ANKRD17 variants. Case 1 describes a fetus with multiple congenital anomalies, where genetic analysis revealed a microdeletion at 4q13.3 truncating the ANKRD17 gene. Case 2 involves a 12-year-old male presenting with mild ID and progressive social impairments, associated with a NM_032217.5: c.1252 C > T (p.Arg418*) variation in ANKRD17. Our study highlighted in mouse models an association between Ankrd17 haploinsufficiency and deficits in social behavior, spatial learning and memory, as well as elevated anxiety. Furthermore, our studies suggest dysregulation of synaptic proteins and mitochondrial function, along with impaired neural circuits following Ankrd17 knockdown. These results expand the genetic and phenotypic spectrum of ANKRD17-related disorders, underscore the critical role of mitochondrial dysfunction in the pathophysiology of ANKRD17-related ID and ASD. En ligne : https://dx.doi.org/10.1186/s11689-025-09619-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=576 Reflections on the genetics-first approach to advancements in molecular genetic and neurobiological research on neurodevelopmental disorders / Anne B. ARNETT in Journal of Neurodevelopmental Disorders, 13 (2021)
![]()
[article]
Titre : Reflections on the genetics-first approach to advancements in molecular genetic and neurobiological research on neurodevelopmental disorders Type de document : texte imprimé Auteurs : Anne B. ARNETT, Auteur ; Tianyun WANG, Auteur ; Evan E. EICHLER, Auteur ; Raphael A. BERNIER, Auteur Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/genetics Genomics Humans Intellectual Disability/genetics Molecular Biology Neurodevelopmental Disorders/genetics Excitatory/inhibitory Genetics-first Molecular genetics Neurobiology Neurodevelopmental disorders Index. décimale : PER Périodiques Résumé : BACKGROUND: Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and intellectual disability (ID), are common diagnoses with highly heterogeneous phenotypes and etiology. The genetics-first approach to research on NDDs has led to the identification of hundreds of genes conferring risk for ASD, ID, and related symptoms. MAIN BODY: Although relatively few individuals with NDDs share likely gene-disruptive (LGD) mutations in the same gene, characterization of overlapping functions, protein networks, and temporospatial expression patterns among these genes has led to increased understanding of the neurobiological etiology of NDDs. This shift in focus away from single genes and toward broader gene-brain-behavior pathways has been accelerated by the development of publicly available transcriptomic databases, cell type-specific research methods, and sequencing of non-coding genomic regions. CONCLUSIONS: The genetics-first approach to research on NDDs has advanced the identification of critical protein function pathways and temporospatial expression patterns, expanding the impact of this research beyond individuals with single-gene mutations to the broader population of patients with NDDs. En ligne : https://dx.doi.org/10.1186/s11689-021-09371-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=574
in Journal of Neurodevelopmental Disorders > 13 (2021)[article] Reflections on the genetics-first approach to advancements in molecular genetic and neurobiological research on neurodevelopmental disorders [texte imprimé] / Anne B. ARNETT, Auteur ; Tianyun WANG, Auteur ; Evan E. EICHLER, Auteur ; Raphael A. BERNIER, Auteur.
Langues : Anglais (eng)
in Journal of Neurodevelopmental Disorders > 13 (2021)
Mots-clés : Autism Spectrum Disorder/genetics Genomics Humans Intellectual Disability/genetics Molecular Biology Neurodevelopmental Disorders/genetics Excitatory/inhibitory Genetics-first Molecular genetics Neurobiology Neurodevelopmental disorders Index. décimale : PER Périodiques Résumé : BACKGROUND: Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and intellectual disability (ID), are common diagnoses with highly heterogeneous phenotypes and etiology. The genetics-first approach to research on NDDs has led to the identification of hundreds of genes conferring risk for ASD, ID, and related symptoms. MAIN BODY: Although relatively few individuals with NDDs share likely gene-disruptive (LGD) mutations in the same gene, characterization of overlapping functions, protein networks, and temporospatial expression patterns among these genes has led to increased understanding of the neurobiological etiology of NDDs. This shift in focus away from single genes and toward broader gene-brain-behavior pathways has been accelerated by the development of publicly available transcriptomic databases, cell type-specific research methods, and sequencing of non-coding genomic regions. CONCLUSIONS: The genetics-first approach to research on NDDs has advanced the identification of critical protein function pathways and temporospatial expression patterns, expanding the impact of this research beyond individuals with single-gene mutations to the broader population of patients with NDDs. En ligne : https://dx.doi.org/10.1186/s11689-021-09371-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=574 Overcoming genetic and cellular complexity to study the pathophysiology of X-linked intellectual disabilities / Dayne MARTINEZ in Journal of Neurodevelopmental Disorders, 16 (2024)
![]()
[article]
Titre : Overcoming genetic and cellular complexity to study the pathophysiology of X-linked intellectual disabilities Type de document : texte imprimé Auteurs : Dayne MARTINEZ, Auteur ; Evan JIANG, Auteur ; Zhaolan ZHOU, Auteur Langues : Anglais (eng) Mots-clés : Female Humans Pregnancy Chromosomes, Human, X Genes, X-Linked/genetics Intellectual Disability/genetics Mosaicism X Chromosome Inactivation/genetics Index. décimale : PER Périodiques Résumé : X-linked genetic causes of intellectual disability (ID) account for a substantial proportion of cases and remain poorly understood, in part due to the heterogeneous expression of X-linked genes in females. This is because most genes on the X chromosome are subject to random X chromosome inactivation (XCI) during early embryonic development, which results in a mosaic pattern of gene expression for a given X-linked mutant allele. This mosaic expression produces substantial complexity, especially when attempting to study the already complicated neural circuits that underly behavior, thus impeding the understanding of disease-related pathophysiology and the development of therapeutics. Here, we review a few selected X-linked forms of ID that predominantly affect heterozygous females and the current obstacles for developing effective therapies for such disorders. We also propose a genetic strategy to overcome the complexity presented by mosaicism in heterozygous females and highlight specific tools for studying synaptic and circuit mechanisms, many of which could be shared across multiple forms of intellectual disability. En ligne : https://dx.doi.org/10.1186/s11689-024-09517-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=575
in Journal of Neurodevelopmental Disorders > 16 (2024)[article] Overcoming genetic and cellular complexity to study the pathophysiology of X-linked intellectual disabilities [texte imprimé] / Dayne MARTINEZ, Auteur ; Evan JIANG, Auteur ; Zhaolan ZHOU, Auteur.
Langues : Anglais (eng)
in Journal of Neurodevelopmental Disorders > 16 (2024)
Mots-clés : Female Humans Pregnancy Chromosomes, Human, X Genes, X-Linked/genetics Intellectual Disability/genetics Mosaicism X Chromosome Inactivation/genetics Index. décimale : PER Périodiques Résumé : X-linked genetic causes of intellectual disability (ID) account for a substantial proportion of cases and remain poorly understood, in part due to the heterogeneous expression of X-linked genes in females. This is because most genes on the X chromosome are subject to random X chromosome inactivation (XCI) during early embryonic development, which results in a mosaic pattern of gene expression for a given X-linked mutant allele. This mosaic expression produces substantial complexity, especially when attempting to study the already complicated neural circuits that underly behavior, thus impeding the understanding of disease-related pathophysiology and the development of therapeutics. Here, we review a few selected X-linked forms of ID that predominantly affect heterozygous females and the current obstacles for developing effective therapies for such disorders. We also propose a genetic strategy to overcome the complexity presented by mosaicism in heterozygous females and highlight specific tools for studying synaptic and circuit mechanisms, many of which could be shared across multiple forms of intellectual disability. En ligne : https://dx.doi.org/10.1186/s11689-024-09517-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=575 Autistic behavior is a common outcome of biallelic disruption of PDZD8 in humans and mice / Stijn VAN DE SOMPELE ; Clemence LIGNEUL ; Camille CHATELAIN ; Christophe BARREA ; Jason P. LERCH ; Beatrice M. FILIPPI ; Serpil ALKAN ; Elfride DE BAERE ; Jamie JOHNSTON ; Steven J. CLAPCOTE in Molecular Autism, 16 (2025)
![]()
PermalinkClinical impact and in vitro characterization of ADNP variants in pediatric patients / Chuanhui GE in Molecular Autism, 15 (2024)
![]()
PermalinkCross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders / Kaiqin LI in Journal of Autism and Developmental Disorders, 52-3 (March 2022)
![]()
PermalinkIdentifying SETBP1 haploinsufficiency molecular pathways to improve patient diagnosis using induced pluripotent stem cells and neural disease modelling / Nicole C. SHAW in Molecular Autism, 15 (2024)
![]()
PermalinkNovel Variants of the SMARCA4 Gene Associated with Autistic Features Rather Than Typical Coffin-Siris Syndrome in Eight Chinese Pediatric Patients / Yanyan QIAN in Journal of Autism and Developmental Disorders, 52-11 (November 2022)
![]()
Permalink

